Non-alcoholic steatohepatitis (NASH) is typically associated with pro-apoptotic caspase activation. A potential role for proinflammatory caspases remains incompletely understood. Our aims were to examine a potential role of caspase-1 in the development of liver damage and fibrosis in NASH. C57BL/6 wild type (WT) developed marked steatohepatitis, activation, fibrosis and increased hepatic caspase-1 and interleukin-1b expression when placed on the methionine-and cholinedeficient (MCD) diet. Marked caspase-1 activation was detected in the liver of MCD-fed mice. Hepatocyte and nonparenchymal fractionation of the livers further demonstrated that caspase-1 activation after MCD feeding was mainly localized to non-parenchymal cells. Caspase-1-knockout (Casp1 À/À ) mice on the MCD diet showed marked reduction in mRNA expression of genes involved in inflammation and fibrogenesis (tumor necrosis factor-a was 7.6-fold greater in WT vs Casp1 À/À MCD-fed mice; F4/80 was 1.5-fold greater in WT vs Casp1 À/À MCD-fed mice; a-smooth muscle actin was 3.2-fold greater in WT vs Casp1 À/À MCD-fed mice; collagen 1-a was 7.6-fold greater in WT vs Casp1 À/À MCD-fed mice; transforming growth factor-b was 2.4-fold greater in WT vs Casp1 À/À MCD-fed mice; cysteine-and glycine-rich protein 2 was 3.2-fold greater in WT vs Casp1 À/À MCD-fed mice). Furthermore, Sirius red staining for hepatic collagen deposition was significantly reduced in Casp1 À/À MCD-fed mice compared with WT MCD-fed animals. However, serum alanine aminotransferase levels, caspase-3 activity and terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive cells were similar in Casp1 À/À and WT mice on the MCD diet. Selective Kupffer cell depletion by clodronate injection markedly suppressed MCD-induced caspase-1 activation and protected mice from fibrogenesis and fibrosis associated with this diet. The conclusion of this study is that it uncovers a novel role for caspase-1 in inflammation and fibrosis during NASH development.
Non-alcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver disease affecting both adults and children, and is strongly associated with obesity and insulin resistance. 1, 2 One in three adults and one in ten children or adolescents in the United States have hepatic steatosis, a stage within the spectrum of NAFLD, that is characterized by triglyceride accumulation in liver cells and follows a benign non-progressive clinical course. 3, 4 Non-alcoholic steatohepatitis (NASH) is defined as lipid accumulation with evidence of cellular damage, inflammation and different degrees of scarring or fibrosis. 5 NASH is a serious condition, as approximately 25% of these patients progress to cirrhosis and its feared complications of portal hypertension, liver failure and hepatocellular carcinoma. [6] [7] [8] The pathogenesis of NAFLD/NASH, in particular the mechanisms responsible for liver injury and disease progression, remains incompletely understood, but are of significant biomedical importance, as identification of these processes may help to identify novel diagnostic and therapeutic targets for this highly prevalent and potentially serious disease.
Since the original description that caspase activation and hepatocyte apoptosis are characteristic pathological features in the liver of NASH patients, 9 a growth of data have demonstrated a key role for caspase-dependent cell death in NASH pathogenesis. [10] [11] [12] [13] Caspases are a family of cysteine proteases with unique substrate specificities that have a central role in the apoptotic machinery. 14, 15 They are synthesized as inert zymogens and upon receipt of apoptotic stimuli, cells activate initiator caspases, such as caspase-1, -2, -8, -9 and -10 that, in turn, proteolytically cleave and activate effector caspases, including caspase-3, -6 and -7. Caspases have been further categorized as either proinflammatory or proapoptotic, depending upon their participation in these cellular programs. The proinflammatory caspases include caspase-1, -11 and -12 in mouse and caspase-1, -4 and -5 in human. 16 Targeting caspase activity and apoptosis has gained significant attention for developing of novel therapeutic diagnostic strategies for NASH patients. Recent data suggest that pancaspase inhibition protects again diet-induced steatohepatitis in different dietary murine models. [17] [18] [19] These pan-caspase inhibitors, not only inhibit caspase-mediated cellular apoptosis, but also block the caspase-1-dependent processing and activation of various proteins with functions in inflammation and tissue repair during tissue damage. However, the contribution of caspase-1-dependent processes to liver injury and fibrosis remains unclear. In the present study, we examined the occurrence and significance of caspase-1 activation in NASH.
EXPERIMENTAL PROCEDURES Animal Studies
These experimental protocols were approved by the Institutional Animal Care and Use Committee at the Cleveland Clinic. Male C57BL/6 mice, 20 -25 g of body weight, were purchased from Jackson Laboratory. C57BL/6 caspase-1knockout (Casp1 À/À ) mice (generously provided by Dr Richard Flavell from Yale University, New Haven, CT, USA) were described previously. 20, 21 Mice were placed on a methionine-and choline-deficient (MCD) diet (TD 90262, Teklad Mills, Madison, WI, USA), which has been extensively shown to result in steatosis associated with significant inflammation and progressive fibrosis, pathologically similar to human severe steatohepatitis. 22, 23 In this model, steatosis results from both decreased mitochondrial oxidation of fatty acids and decreased export of fatty acids in the form of very low-density lipoprotein. 24 Identical groups of animals (n ¼ 5-7 in each group) received a standard diet consisting of 5% fat (TD 2918, Teklad Mills) to act as controls (CTL). Total body weight was measured at 0, 1, 3 and 6 weeks. Animals in each group were killed after 6 weeks on respective diets.
In selective studies, C57BL/6 male mice of 20-25 g in weight were placed on the MCD diet for the intravenous injection of liposomes encapsulating phosphate vehicle (PBS) or clodronate (CLOD; n ¼ 3-7 in each group). After 5 weeks of MCD diet, animals were injected twice 5 days apart with 0.1 ml per 10 g of body weight of a 1 mg/ml suspension of liposomes as previously described. 25 Animals in each group were killed after 6 weeks on respective treatments.
Cell Lines and Culture
Primary mouse hepatocytes and total non-parenchymal cells were isolated from C57BL/6 mice on a 6-week MCD diet. The mice were anesthetized and the livers were perfused with warm oxygenated Hanks (À) with 1 mM EGTA and 10 mM HEPES, followed by Williams E media containing 10 mg collagenase per mouse. Hepatocytes were collected after centrifugation, and resulting cell suspensions were used to collect total non-parenchymal cells with a Percoll gradient centrifugation. Caspase-1 and interleukin (IL)-1b expression was determined by western blot analysis as detailed below.
Histopathology, Immunostaining and Serum Assays Blood samples and liver tissue were collected under deep anesthesia after a 5-h fast as previously described in detail. 26 Liver tissue was fixed in 10% formalin and embedded in Tissue Path (Fisher Scientific, Pittsburgh, PA, USA). Hematoxylin and eosin (H&E) as well as Oil red O-stained liver specimens were evaluated by light microscopy. Liver triglyceride determinations were performed using a specific kit following manufacturer's instructions (Pointe Scientific). Serum alanine aminotransferase (ALT) determinations were performed using a commercial kit (Sigma Diagnostics). Individual features, including degree of steatosis, inflammation and ballooning, were assessed in the MCD and CTL-fed animals by an experienced pathologist (BGP) in a blinded fashion. Steatosis, inflammation and ballooning were scored on the basis of the NAFLD activity score. 27 
Assessment of Hepatic Caspase-1 Activation and Cellular Localization
Caspase-1 activity was determined using 200 mg whole-liver protein with the Caspase-1 Fluorometric Assay Kit (cat. ab39412) purchased from Abcam. Immunohistochemistry for caspase-1 was performed using paraffin-embedded liver tissue using standard DAB technique. The following primary antibodies were used: rabbit anti-Caspase-1 (cat. 06-503 dilution 1:80) purchased from Millipore.
Apoptosis Assessment
Tissue sections (4 mm) were prepared, and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was performed following manufacturer's instructions (in situ cell death detection kit; Roche Molecular Biochemicals, Mannheim, Germany). Caspase activation was quantified by immunostaining for active caspase-3, using a cleaved caspase-3 antibody (Cell Signaling). Hepatocyte apoptosis in liver sections was quantitated by counting the number of TUNEL-positive or active caspase-3-positive cells in five random microscopic fields ( Â 40), as previously described. 12 
Determination of Liver Fibrosis
Liver fibrosis was quantified with Sirius Red. Direct Red 80 and Fast Green FCF (color index 42053) were provided by Sigma-Aldrich. Liver sections were incubated in the dark for 2 h at room temperature with an aqueous solution of saturated picric acid containing 0.1% Fast Green FCF and 0.1% Direct Red. 26 Stained slides were washed slowly under running distilled water for 6 min, dehydrated (3 min for each step), mounted, and examined by light microscopy. Redstained collagen fibers were quantitated by digital image analysis, excluding blood vessels.
Immunoblot and Immunoprecipitation Analysis
Total liver protein (500 mg) was immunoprecipitated with 5 mg rabbit anti-caspase-1 antibody (cat. 06-503) purchased 
Statistical Analysis
All data were expressed as the mean±s.e.m. unless otherwise indicated. Differences between three or more groups were compared by an ANOVA analysis followed by a post-hoc Newman-Keuls test, parametric test or the Kruskall-Wallis nonparametric test. Differences between two groups of normalized data were compared by a two-sided Student's t-test.
Differences were considered to be statistically significant at Po0.05. All statistical analysis was performed using GraphPad Prism 4.0c. Table 1 Histological analysis of steatosis, inflammation, ballooning and overall NAFLD activity score in MCD and CTL-fed animals Caspase-1 activation in NASH LJ Dixon et al
RESULTS

Hepatic Caspase-1 Activation Is a Prominent Pathological Feature in Experimental NASH
To investigate the role of caspase-1 activation in the pathogenesis of NASH, we initially placed C57BL/6 mice on the MCD diet, which has been extensively shown to be associated with progressive fibrosing steatohepatitis, pathologically similar to human severe steatohepatitis. 22, 23 After 6 weeks on the respective diets, we observed significant hepatic fat accumulation induced by MCD feeding (Figure 1a ), in conjunction with an increase in histological parameters of liver injury, including hepatic inflammation and hepatocyte ballooning ( Figure 1a and Table 1 ). Expression of caspase-1 was significantly increased in mice on the MCD feeding compared with CTL ( Figure 1b ). This was accompanied by increased mRNA levels of ASC, a key component of the inflammasome, the protein platform that activates caspase-1 as well as IL-1, but not of IL-18 ( Figure 1b ). These changes in the livers of mice fed the MCD diet were associated with a marked increased in inflammasome activation (Figure 1c and d) , as well as caspase-1 protein expression and activity levels ( Figure  1e -g). Consistent with these data, liver active mature IL-1b protein expression was also significantly increased in MCDfed animals compared with CTL mice (Figure 1h and i). Immunohistochemical analysis of liver sections from the two groups of mice showed that caspase-1 was primarily localized to non-parenchymal sinusoidal cells, and to a lesser extent to hepatocytes (Figure 1j ). This was further confirmed by fractionation of the liver tissue from MCD-fed animals into hepatocytes and total non-parenchymal cells further demonstrating that caspase-1 and IL-1b protein expression was markedly enhanced in the non-parenchymal fraction compared with hepatocytes ( Figure 1k ).
Caspase-1 Suppression Is Associated with Dissociation between Hepatic Triglyceride Accumulation and Inflammatory Activity
Having established the presence of inflammasome activation and increased caspase-1 activity in the liver of MCD-fed mice, we next sought to investigate whether caspase-1 participates in NASH development using Casp1 À/À . We first investigated whether Casp1 À/À mice are resistant to hepatic steatosis and inflammation. C57BL/6 wild type (WT), Casp1 knock-out mice were placed on either a MCD diet or CTL diet (n ¼ 5-7 in each group) for 6 weeks. WT mice and Casp1 À/À mice had similar weight changes on the MCD diet (Figure 2a ). However, microscopic examination of H&E and Oil Red-O staining showed that Casp1 À/À mice on the MCD diet developed more significant macrovesicular hepatic steatosis, compared with the WT mice on this diet (Figure 2b and c). Consistently with these results, hepatic triglyceride levels were significantly more elevated in Casp1 À/À mice compared with WT mice on the MCD diet (Figure 2d ). Histological examination of liver samples of other individual features associated with NASH demonstrated a decrease in inflammatory foci, resulting in lower inflammatory activity scores in the Casp1 À/À mice on the MCD diet compared with WT mice on this diet (Table 1) . However, the total NAFLD activity score was similar in the two groups of mice as mainly as a result of higher degree of steatosis, as well as higher levels of hepatocyte ballooning present in MCD-fed Casp1 À/À mice ( Table 1) . Serum ALT levels were similarly elevated in Casp1 À/À mice and WT mice on the MCD diet compared with animals fed the CTL diet (Figure 2e ). We next examined the inflammatory state of the liver at the molecular and cellular level, and found a marked reduction in mRNA levels of TNFa, F4/80 and CD11c in the MCD-fed Casp1 À/À mice compared with the WT animals on the MCD diet (Figure 2f-h) .
HSC Activation and Collagen Deposition Induced by the MCD Diet are Decreased by Caspase-1 Suppression Independent of Caspase-3 Activation and Apoptosis
The findings of a key role of caspase-1 in hepatocyte injury and inflammatory signaling, two events that have been linked to HSC activation, led us to further examine the role of caspase-1 in fibrogenesis and fibrosis induced by the MCD diet. Although, as expected, after 6 weeks on the MCD diet, WT animals showed a marked increase in the mRNA expression of genes involved in HSC activation and fibrogenesis, such as TGFb, aSMA, COL1A1 and CRP2 (Figure 3a-d) .
These changes were significantly reduced in the Casp1 À/À MCD-fed mice. In addition, aSMA protein expression was increased in WT MCD-fed mice, whereas it was significantly reduced in Casp1 À/À MCD-fed mice (Figure 3e and f). More importantly, an almost four-fold increase in collagen deposition, as demonstrated by Sirius red staining of liver tissue coupled to quantitation by digitized image analysis, was present in WT animals on the MCD diet compared with the WT animals on the CTL diet (Figure 3g and h), whereas these increases in collagen deposition were significantly less prominent in the Casp1 À/À mice, although still higher than in mice on the CTL diet (Figure 3g and h) . We next quantified the amount of hepatocellular cell death present in the various groups of mice. Caspase-3 activation and TUNEL-positive hepatocytes were increased to a similar extent in both WT animals and Casp1 À/À mice on the MCD diet compared with animals on the CTL diet (Figure 4a-d) .
Taken together, these observations suggest that during NASH development, caspase-1 activation in hepatocytes has an important role in hepatocellular injury, inflammatory signaling, HSC activation and hepatic fibrosis, independent of caspase-3 activation and hepatocellular apoptosis.
Selective Kupffer Cell Depletion in MCD-Induced Steatohepatitis Reduces Caspase-1 Activation and Protects Against Fibrogenesis and Fibrosis
The findings of inflammasome activation and marked increase in caspase-1 and IL-1b, mainly from non-parenchymal cells of the liver, on MCD-fed animals, in conjunction with the fact that the inflammasome is primarily present in monocytes and macrophages, led us to the hypothesis that Kupffer cells, the liver resident macrophages, are the main source for these changes. To test this hypothesis, we next examine the effects of selective depletion of Kupffer cells on caspase-1 expression and MCD-induced liver damage. C57BL/6 WT mice on a 6-week MCD diet were injected twice during the last week of the diet with CLOD or PBS liposomes intravenously. Hepatic steatosis was unchanged between the CLOD-and PBS-treated MCD-fed mice (Figure 5a ). Hepatic F4/80 immunostaining demonstrated the effectiveness of CLOD treatment in the depletion of Kupffer cells in the liver (Figure 5a ). This was further confirmed by measurement of mRNA levels by RT-PCR of TNFa, F4/80 and CD68, which were markedly decreased in the CLOD-treated group com-pared with the PBS-treated MCD-fed mice (Figure 5b ). More importantly, caspase-1 protein expression was also significantly reduced in CLOD-treated MCD-fed mice as detected by both immunohistochemistry of liver tissue and immunoblot analysis of whole-liver lysates (Figure 5c-e ). These changes were associated with a decrease in the expression of genes involved in fibrogenesis (Figure 5f ), as well as a dramatical reduction in collagen deposition in CLOD-treated MCD-fed mice (Figure 5g ). These data strongly suggest that Kupffer cells are the main cellular source of active caspase-1 in MCD-diet-induced steatohepatitis.
DISCUSSION
The principle findings of this study relate to the role of caspase-1 during NASH development. The results demonstrate Caspase-1 activation in NASH LJ Dixon et al that NASH induced by MCD feeding is associated with caspase-1 activation in the liver, whereas caspase-1 suppression is associated with dissociation between hepatic triglyceride accumulation and inflammatory activity, and protects against HSC activation and fibrosis development. These effects were independent of caspase-3 activation and hepatocyte cell death. Furthermore, we identified Kupffer cells as a key cellular source of active caspase-1 in MCD diet-induced steatohepatitis.
Since the original description that caspase-3 and -7 activation and TUNEL-positive cells are characteristic pathological features in the liver of NASH patients, 9 a growth of data, mainly from experimental studies, have suggested that caspase activation, mainly caspase-3, is a key process involved in NASH pathogenesis. 10 As a result, the targeting of caspase activity has gained significant attention for developing of both novel therapeutic as well as diagnostic strategies for NASH patients. A recent pre-clinical study tested a 
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LJ Dixon et al pan-caspase inhibitor VX-166 in an animal model of NASH. 19 Obese leptin receptor-deficient db/db mice were fed MCD diet to induce NASH and liver fibrosis. Mice gavaged daily with VX-166 showed a marked reduction in hepatic caspases activity, decreased levels of mature IL-1b and IL-18 in the liver and liver fibrosis. Caspases belong to a family of highly conserved cysteinedependent aspartate-specific acid proteases that use a cysteine residue as the catalytic nucleophile and share a stringent specificity for cleaving their substrates after aspartic acid residues in target proteins. 15 They are synthesized as inert zymogens, and upon receiving apoptotic stimuli, cells activate initiator caspases, such as caspase-1, -2, -8, -9 and -10 that, in turn, proteolytically cleave and activate effector caspases, including caspase-3, -6 and -7. 16 Caspases have been further categorized as either proinflammatory or proapoptotic, depending upon their participation in these cellular programs. The proinflammatory caspases include caspase-1, -11 and -12 in mouse and caspase-1, -4 and -5 in human. The relative contribution of pro-apoptotic vs proinflammatory caspases to liver pathology during NASH development as well as in the protective effects of pan-caspase inhibitors remain incompletely understood. Our results confirmed the findings from Witek et al 19 demonstrating that MCD feeding results in marked caspase-1 activation. Our current data further extend these observations by demonstrating that activated cleaved caspase-1 localized predominantly on non-parenchymal sinusoidal cells in the liver, and to a lesser extent in hepatocytes. Suppression of caspase-1 activation resulted in decreased tissue inflammation despite an increase in triglyceride deposition and hepatic steatosis. Moreover, although as expected after 6 weeks on the MCD diet, WT animals showed a marked increase in the expression of various genes involved in HSC activation and fibrogenesis; these changes were significantly reduced in the Casp1 À/À mice. More importantly, WT animals on the MCD diet, but not Casp1 À/À mice, showed a significant increase in collagen deposition. These changes were independent of hepatocyte caspase-3 activation, hepatocellular injury, as evidenced by ballooning degeneration of hepatocytes and elevation of serum transaminases, and cell death, which occurred to a similar extent in both WT animals and Casp1 À/À mice on the MCD diet. The precise mechanisms resulting in the catalytic processing of pro-caspase-1 into its enzymatically active form during NASH development will require further investigation, but multiple processes that are known to induce the assembly of the inflammasome, the caspase-1-activating complex, such as increase in reactive oxygen species production, and lysosomal permeabilization and release of cathepsins into the cytosol are known to be present in both experimental model of NASH as well as humans with this condition. 13, 28 Figure 6 Proposed model for role of inflammasome and caspase-1 activation in tissue damage and fibrosis in steatohepatitis. In the process of nonalcoholic steatohepatitis (NASH) development, different lipotoxic substances, such as cholesterol crystals or free fatty acids, may induce the processing and activation of caspase-1 predominantly in Kupffer cells in the liver, and to a lesser extent in hepatocytes. Hepatic caspase-1 activation induce cleavage of interleukin (IL)-1 into its mature form IL-1b, resulting in increased inflammation and tissue damage, including the activation of hepatic stellate cells. This results in fibrogenesis and fibrosis development. Therapy target at inhibiting the inflammasome or caspase-1 activation may be a novel therapeutic target for treatment of NASH.
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